Breaking news China: Provisional assent for Pfizer’s COVID pill Febbraio 12, 2022 China’s National Medical Products Administration announced on Saturday it has given provisional approval for the use of Paxlovid, Pfizer Inc.’s oral treatment against COVID-19. The agency sai…
